Description
Small Molecules in Hematology (3rd Ed., 3rd ed. 2018)
Recent Results in Cancer Research Series, Vol. 212
Coordinator: Martens Uwe M.
Language: EnglishSubjects for Small Molecules in Hematology:
Publication date: 01-2019
Support: Print on demand
Publication date: 08-2018
Support: Print on demand
Description
/li>Contents
/li>Biography
/li>Comment
/li>
This book, written by respected experts, discusses in detail the latest developments in targeted therapy for hematologic malignancies using small molecules. It covers a wide range of small molecules including tyrosine kinase inhibitors, immunomodulatory drugs, the IDH-2 inhibitor enasidenib, the BCL-2 inhibitor venetoclax, and the proteasome inhibitor carfilzomib. For each molecule, aspects such as the chemical structure, mechanism of action, drug targets, drug interactions, preclinical studies, clinical trials, treatment applications, and toxicity are discussed.
Extensive research into the molecular mechanisms of cancer has heralded a new age of targeted therapy. The field of precision cancer therapy is now growing rapidly, and the advances being made will mean significant changes in the treatment algorithms for cancer patients. Numerous novel targets that are crucial for the survival of cancer cells can be attacked by small molecules such as protein tyrosine kinase inhibitors. An accompanying volume addresses the use of small molecules in oncology, and the two volumes together represent the third edition of the book originally published under the same title.
Discusses the most recent developments in targeted therapy in hematology using small molecules
Describes chemical structure, mechanism of action, drug targets, and drug interactions
Examines preclinical studies, clinical trials, and treatment applications
These books may interest you
Small Molecules in Oncology 126.59 €
Small Molecules in Oncology 105.49 €
Small Molecules in Oncology 126.59 €